This Evidence to Practice report highlights the menopause guidelines recently published by the National Institute of Health and Care Excellence and suggests directions for full implementation.
Article InformationCorresponding Author: Mary Ann Lumsden, MD, MB, BS, BSc, FRCOG, Department of Reproductive and Maternal Medicine, School of Medicine, University of Glasgow, New Lister Bldg, Glasgow Royal Infirmary, Glasgow G31 2ER, Scotland (Maryann.firstname.lastname@example.org).
Published Online: June 20, 2016. doi:10.1001/jamainternmed.2016.2761.
Conflict of Interest Disclosures: None reported.
Group Information: The members of the Guideline Development Group for Menopause: Diagnosis and Management (NICE Clinical Guideline No. 23) are as follows: Medical professional members: Terry Aspray, Musculoskeletal Unit, Freeman Hospital; Melanie Davies, University College London Hospitals (until November 2014); Deborah Holloway, Guys and St Thomas’s NHS Foundation Trust; Sally Hope, GP, Oxford, Oxfordshire; Mary Ann Lumsden, University of Glasgow and Glasgow Royal Infirmary; Prunella Neale, Herschel Medical Centre, Slough; Nicholas Panay, Queen Charlotte’s and Chelsea & Chelsea and Westminster Hospitals, London; Anthony Parsons, Coventry and Warwickshire Partnership Trust; Imogen Shaw, GP, Finchingfield, Essex; and Christine West, Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh (from Jan 2015). Lay members: Claire Bowring, Deborah Keatley, and Sara Moger. Expert advisors: Charlotte Coles (until October 2014), Addenbrooke’s Hospital, Cambridge; Peter Collins, Imperial College London; Rebecca Hardy, MRC Unit for Lifelong Health and Aging, University College London; Adrian Harnett, Norfolk and Norwich University Hospital; and Myra Hunter, King’s College London.